Temporal progression of mediastinal lymphadenopathy in idiopathic pulmonary fibrosis

被引:0
|
作者
Wallis, Tim J. M. [1 ,2 ]
Gudmundsson, Eyjolfur [3 ]
Pontoppidan, Katarina [1 ]
Mogulkoc, Nesrin [4 ]
Sava, Recep [5 ]
Unat, Omer Selim [4 ]
Vedwan, Katharine [6 ]
Battison, Sobana [6 ]
Thompson, Fiona J. [1 ]
Brereton, Christopher J. [1 ,2 ]
Marshall, Ben G. [1 ,2 ]
Fletcher, Sophie V. [1 ,2 ]
Richeldi, Luca [1 ,7 ]
Jacob, Joseph [3 ,8 ]
Jones, Mark G. [1 ,2 ]
机构
[1] Southampton Univ Hosp, Natl Inst Hlth Res, Southampton Biomed Res Ctr, Southampton, Hants, England
[2] Univ Southampton, Sch Clin & Expt Sci, Fac Med, Southampton, Hants, England
[3] UCL, Ctr Med Image Comp, London, England
[4] Ege Univ Hosp, Dept Resp Med, Izmir, Turkey
[5] Ege Univ Hosp, Dept Radiol, Izmir, Turkey
[6] Southampton Univ Hosp, Dept Cardiothorac Radiol, Southampton, Hants, England
[7] Univ Cattolica Sacro Cuore, Fdn Policlin A Gemelli, Unita Operat Complessa Pneumol, Rome, Italy
[8] UCL, UCL Resp, London, England
基金
英国惠康基金;
关键词
LYMPH-NODE ENLARGEMENT; DISEASE; PREVALENCE; CT;
D O I
10.1183/13993003.00024-2022
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
引用
收藏
页数:4
相关论文
共 50 条
  • [21] Comparison of disease progression subgroups in idiopathic pulmonary fibrosis
    Karkkainen, Miia
    Kettunen, Hannu-Pekka
    Nurmi, Hanna
    Selander, Tuomas
    Purokivi, Minna
    Kaarteenaho, Riitta
    BMC PULMONARY MEDICINE, 2019, 19 (01)
  • [22] Comparison of disease progression subgroups in idiopathic pulmonary fibrosis
    Miia Kärkkäinen
    Hannu-Pekka Kettunen
    Hanna Nurmi
    Tuomas Selander
    Minna Purokivi
    Riitta Kaarteenaho
    BMC Pulmonary Medicine, 19
  • [23] Pirfenidone reduced disease progression in idiopathic pulmonary fibrosis
    Lake, Fiona
    ANNALS OF INTERNAL MEDICINE, 2014, 161 (08)
  • [24] Autoantibodies are associated with disease progression in idiopathic pulmonary fibrosis
    Koether, Katerina
    Besnard, Valerie
    Sandig, Hilary
    Carruthers, Alan
    Miranda, Elena
    Grootenboer-Mignot, Sabine
    Taille, Camille
    Chevret, Sylvie
    Valeyre, Dominique
    Nunes, Hilario
    Israel-Biet, Dominique
    Lim, Wei Keat
    Cottin, Vincent
    Corkill, Dominic
    Dobson, Claire
    Groves, Maria
    Ferraro, Franco
    Guenzi, Edouard
    Huang, Ling
    Sulikowski, Michal
    Mailleux, Arnaud
    Murray, Lynne Anne
    Mustelin, Thomas
    Strickland, Ian
    Sleeman, Matthew A.
    Crestani, Bruno
    EUROPEAN RESPIRATORY JOURNAL, 2023, 61 (05)
  • [25] The Role of Bacteria in the Pathogenesis and Progression of Idiopathic Pulmonary Fibrosis
    Molyneaux, Phillip L.
    Cox, Michael J.
    Willis-Owen, Saffron A. G.
    Mallia, Patrick
    Russell, Kirsty E.
    Russel, Anne-Marie
    Murphy, Elissa
    Johnston, Sebastian L.
    Schwarte, David A.
    Wells, Athol U.
    Cookson, William O. C.
    Maher, Toby M.
    Moffatt, Miriam F.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 190 (08) : 906 - 913
  • [26] Disease Progression in Idiopathic Pulmonary Fibrosis FVC Is Not Enough
    Behr, Juergen
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 196 (09) : 1094 - 1095
  • [27] Sex differences in physiological progression of idiopathic pulmonary fibrosis
    Han, M. K.
    Murray, S.
    Fell, C. D.
    Flaherty, K. R.
    Toews, G. B.
    Myers, J.
    Colby, T. V.
    Travis, W. D.
    Kazerooni, E. A.
    Gross, B. H.
    Martinez, F. J.
    EUROPEAN RESPIRATORY JOURNAL, 2008, 31 (06) : 1183 - 1188
  • [28] Predictive biomarkers of disease progression in idiopathic pulmonary fibrosis
    Zhu, Weiwei
    Liu, Chunquan
    Tan, Chunting
    Zhang, Jie
    HELIYON, 2024, 10 (01)
  • [29] Idiopathic Pulmonary Fibrosis Nintedanib slows the Progression of the Disease
    Weiss, Johannes
    PNEUMOLOGIE, 2016, 70 (07): : 434 - 434
  • [30] Two Drugs Reduce Progression of Idiopathic Pulmonary Fibrosis
    Slomski, Anita
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 311 (24): : 2472 - 2472